HDAC3在炎症中的作用:机制和治疗含义
Noah Watson1, Sivaraman Kuppuswamy1, William Luke Ledford1
1Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, GA, United States.
Frontiers in immunology
|July 25, 2024
概括
基因组脱乙酶 (HDACs) 调节炎症. 基因组脱乙酶 (HDACs) 调节炎症. 基因组脱乙酶 (HDACs) 调节炎症. 基因组脱乙酶 (HDACs) 调节炎症. 本综述侧重于HDAC3,强调其在各种炎症性疾病中的作用以及其选择性抑制的潜在益处.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 基因组脱乙酶 (HDACs) 是炎症基因表达的关键调节剂.
- 全HDAC抑制剂在疾病中显示出有效性,但它们在炎症中的确切作用尚不清楚.
- 对HDAC的异形特异向可能会减少非向效应.
研究的目的:
- 审查HDAC3在调节炎症反应中的作用.
- 讨论HDAC3在炎症相关病理中的分子机制.
- 为了确定未来研究的知识差距.
主要方法:
- 对HDAC3和炎症研究的文献综述.
- 对HDAC3的炎症调节背后的分子机制的分析.
- 综合各种疾病背景的研究结果.
主要成果:
- 在调节炎症反应方面,HDAC3发挥着重要作用.
- HDAC3与大脑病理,关节炎,心血管疾病,肺病理,过敏症和脏疾病有关.
- 选择性抑制HDAC3在各种炎症病理中表现出有益的影响.
结论:
- HDAC3是炎症的关键调节者,在疾病中发挥着不同的作用.
- 选择性向HDAC3为炎症条件提供了一个有前途的治疗策略.
- 需要进一步的研究来探索HDAC3抑制以改善疾病预后.
相关概念视频
Inflammatory Response
1.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
T Cell Types and Functions
986
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
986
Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
126
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
126
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K


